Epireubicin/cisplatin/capecitabine (ECX)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Epireubicin/cisplatin/capecitabine (ECX), covering 2018-11-02 to 2018-11-02. Get the full timeline:
Most recent: Clinical Trial Update: Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer [Phase 2]